Core Viewpoint - InnoCare Pharma (02577) plans to issue 20.7 million new H-shares at a price of HKD 75.58 per share, representing a discount of approximately 7.88% from the closing price on October 9, 2023 [1] Summary by Categories Share Issuance - The proposed share issuance will account for approximately 3.94% of the enlarged H-share capital and about 2.26% of the total issued shares [1] Financial Details - The total expected proceeds from the share placement are approximately HKD 1.5645 billion, with net proceeds estimated at around HKD 1.5504 billion [1] Use of Proceeds - Approximately 31% of the net proceeds will be allocated for capacity expansion and continuous product upgrades - About 24% will be used to repay interest-bearing debts - Approximately 45% will be designated for working capital and general corporate purposes [1]
英诺赛科(02577)拟配售2070万股 净筹约15.504亿港元